Financials
- Market Capitalization 33.01 M
- Employee 25
- Founded 2000
- CEO Sandesh Seth
- Website www.actiniumpharma.com
- Headquarter Delaware, United States
- FIGI BBG000RQZ245
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
2.8
Fiyat/satışlar oranı
0.88
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 4389 | KYNB Kyntra Bio, Inc. - Common Stock | 8.49 USD | -0.47% | +6.26% | +20.25% | -10.73% | 34.38 M USD | ||
| 4405 | CNTX Context Therapeutics Inc. - Common Stock | 0.36 USD | 0.00% | -12.20% | -42.86% | -56.10% | 33.08 M USD | ||
| 4408 | ACTU Actuate Therapeutics, Inc. - Common stock | 1.37 USD | +5.38% | -18.93% | +22.32% | -66.42% | 32.90 M USD | ||
| 4428 | QNCX Quince Therapeutics, Inc. - Common Stock | 30.55 USD | -4.98% | -7.17% | +12.48% | +1809.38% | 31.07 M USD |